DPDPE
DPDPE ([D-Pen2,D-Pen5]enkephalin) is a synthetic opioid peptide and a selective agonist of the δ-opioid receptor (DOR) which is used in scientific research.[1] It was developed in the early 1980s and was the first highly selective agonist of the DOR to be developed.[1] It was derived from structural modification of met-enkephalin.[2]
 | |
| Clinical data | |
|---|---|
| Other names | L-Tyrosyl-D-penicillamyl-glycyl-L-phenylalanyl-D-penicillamine (2->5)-disulfide; H-Tyr-D-Pen(1)-Gly-Phe-D-Pen(1)-OH |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C30H39N5O7S2 |
| Molar mass | 645.79 g/mol g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
References
- L F Tseong (1 September 1995). Pharmacology of Opioid Peptides. CRC Press. pp. 9–. ISBN 978-3-7186-5632-5.
- Abba Kastin; Abba J. Kastin (28 April 2011). Handbook of Biologically Active Peptides. Academic Press. pp. 1430–. ISBN 978-0-08-046379-7.
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.